[1]Tu S, Okamoto S, Lipton SA, et al. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease[J]. Mol Neurodegener, 2014, 9:48.
[2]Nazem A, Sankowski R, Bacher M, et al. Rodent models of neuroinflammation for Alzheimer’sdisease[J]. J Neuroinflammation, 2015,12:74.
[3]Carret-Rebillat AS, Pace C, Gourmaud S, et al. Neuroinflammation and Aβ accumulation linked to systemic inflammation are decreased by genetic PKR downregulation[J]. Sci Rep, 2015, 5:8489.
[4]Ehninger D, Kempermann G. Paradoxical effects of learning the Morris water maze on adult hippocampal neurogenesis in mice may be explained by a combination of stress and physical activity[J]. Genes Brain Behav, 2006, 5(1):29-39.
[5]Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR[J]. Nucleic Acids Res, 2001, 29(9):e45.
[6]de Leon MJ, Convit A, DeSanti S, et al. Contribution of structural neuroimaging to the early diagnosis of Alzheimer’s disease[J]. Int Psychogeriatr, 1997, 9 Suppl 1:183-190, discussion 247-252.
[7]Sigurdsson EM, Lorens SA, Hejna MJ, et al. Local and distant histopathological effects of unilateral amyloid-beta 25-35 injections into the amygdala of young F344 rats[J]. Neurobiol Aging, 1996, 17(6):893-901.
[8]Delobette S, Privat A, Maurice T. In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat[J]. Eur J Pharmacol, 1997, 319(1):1-4.
[9]Giovannelli L, Casamenti F, Scali C, et al. Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis[J]. Neuroscience, 1995, 66(4):781-792.
[10]Sajan FD, Martiniuk F, Marcus DL, et al. Apoptotic gene expression in Alzheimer’s disease hippocampal tissue[J]. Am J Alzheimers Dis Other Demen,2007,22(4):319-328.
[11]Nakamura S, Murayama N, Noshita T, et al. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801[J]. Eur J Pharmacol, 2006, 548(1-3):115-122.
[12]Ikeya Y, Takeda S, Tunakawa M, et al. Cognitive improving and cerebral protective effects of acylated oligosaccharides in Polygala tenuifolia[J]. Biol Pharm Bull, 2004, 27(7):1081-1085.
[13]Turdi S, Guo R, Huff AF, et al. Cardiomyocyte contractile dysfunction in the APPswe/PS1dE9 mouse model of Alzheimer’s disease[J]. PLoS One, 2009, 4(6):e6033.
[14]Castellano JM, Deane R, Gottesdiener AJ, et al. Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Abeta clearance in a mouse model of beta-amyloidosis[J]. Proc Natl Acad Sci USA, 2012, 109(38):15502-15507.
[15]Sagare AP, Deane R, Zlokovic BV. Low-density lipoprotein receptor-related protein 1: a physiological Abeta homeostatic mechanism with multiple therapeutic opportunities[J]. Pharmacol Ther, 2012, 136(1):94-105.
|